Human immunoglobulin G recognizing fibrinogen-binding surface proteins is protective against both Staphylococcus aureus and Staphylococcus epidermidis infections in vivo

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 2, 2006, Pages 511-518

  Vernachio, John H ^a   Bayer, Arnold S ^b,c   Ames, Brenda ^a   Bryant, Dawn ^a   Prater, Bradley D ^a   Syribeys, Peter J ^a   Gorovits, Elena L ^a   Patti, Joseph M ^a  

^a Inhibitex Inc   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; FIBRINOGEN; FIBRINOGEN BINDING SURFACE PROTEIN; FLUORESCENT DYE; IMMUNOGLOBULIN G; PANGLOBULIN; PROTEIN; PROTEIN CIFA; PROTEIN INH A21; PROTEIN SDRG; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BACTERIAL ENDOCARDITIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG PROTEIN BINDING; FLUORESCENCE; HIGH RISK POPULATION; IN VITRO STUDY; IN VIVO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NEWBORN; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; RABBIT; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; CARRIER PROTEINS; COAGULASE; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 31944433099     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.50.2.511-518.2006     Document Type: Article

References (31)

1. Baker, C., M. Melish, R. Hall, D. Casto, U. Vasan, L. Givner, and the Multicenter Group for the Study of Immune Globulin in Neonates. 1992. Intravenous Immune Globulin for the Prevention of Nosocomial Infection in Low-Birth-Weight Neonates. N. Engl. J. Med. 327:213-219.
2. Baker, C. J., M. A. Rench, F. J. Noya, J. A. Garcia-Prats, and the Neonatal IVIG Study Group. 1990. Role of intravenous immunoglobulin in prevention of late-onset infection in low-birth-weight neonates. Rev. Infect. Dis. 12(Suppl. 4):S463-S469.
3. Bayer, A. S., C. Li, and M. Ing. 1998. Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains. Antimicrob. Agents Chemother. 42:1837-1841.
4. Bayer, A., S., P. M. Sullam, M. Ramos, C. Li, A. L. Cheung, and M. R. Yeaman. 1995. Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains. Infect. Immun. 63:3634-3641.
5. Bloom, B., R. Schelonka, T. Kueser, W. Walker, E. Jung, D. Kaufman, K. Kesler, D. Roberson, J. Patti, and S. Hetherington. 2005. Multicenter study to assess safety and efficacy of INH-A21, a donor-selected human staphylococcal immunoglobulin, for prevention of nosocomial infections in very low birth weight infants. Pediatr. Infect. Dis. J. 24:858-866.
6. Davis, S. L., S. Gurusiddappa, K. W. McCrea, S. Perkins, and M. Hook. 2001. SdrG, a fibrinogen-binding bacterial adhesin of the microbial surface components recognizing adhesive matrix molecules subfamily from Staphylococcus epidermidis, targets the thrombin cleavage site in the Bbeta chain. J. Biol. Chem. 276:27799-27805.
7. Dryla, A., S. Prustomersky, D. Gelbmann, M. Hanner, E. Bettinger, B. Kocsis, T. Kustos, T. Henics, A. Meinke, and E. Nagy. 2005. Comparison of antibody repertoires against Staphylococcus aureus in healthy individuals and in acutely infected patients. Clin. Diagn. Lab. Immunol. 12:387-398.
8. Fanaroff, A., S. Korones, L. Wright, et al. 1994. A controlled trial of intravenous immune globulin to reduce nosocomial infections in very-low-birth-weight neonates. N. Engl. J. Med. 330:1107-1113.
9. Fischer, G. W. 1988. Therapeutic uses of intravenous gammaglobulin for pediatric infections. Pediatr. Clin. N. Am. 35:517-533.
10. Fischer, G. W. 1992. Uses of intravenous globulin to prevent or treat infections. Adv. Pediatr. Infect. Dis. 7:85-108.
11. Foster, T. J., and M. Höök. 1998. Surface proteins of Staphylococcus aureus. Trends Microbiol. 6:484-488.
12. Foster, T. J., and D. McDevitt. 1994. Surface-associated proteins of Staphylococcus aureus: their possible roles in virulence. FEMS Microbiol. Lett. 118:199-205.
13. Horbar, J. D., G. J. Badger, J. H. Carpenter, A. A. Fanaroff, S. Kilpatrick, M. LaCorte, R. Phibbs, and R. F. Soll. 2002. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 110:143-151.
14. Jenson, H., and B. Pollock. 1997. Meta-analysis of the effectiveness of intravenous immune globulin for prevention and treatment of neonatal sepsis. Pediatrics 99:1-11.
15. Klug, D., F. Wallet, S. Kacet, and R. J. Courcol. 2003. Involvement of adherence and adhesion Staphylococcus epidermidis genes in pacemaker lead-associated infections. J. Clin. Microbiol. 41:3348-3350.
16. Martin, J., B. Hamilton, P. Sutton, S. Ventura, F. Menacker, and M. Munson. 2003. Births: final data for 2002. Natl. Vital Stat. Rep. 52:1-113.
17. McCrea, K. W., O. Hartford, S. Davis, D. N. Eidhin, G. Lina, P. Speziale, T. J. Foster, and M. Hook. 2000. The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis. Microbiology 146:1535-1546.
18. McDevitt, D., P. Francois, P. Vaudaux, and T. J. Foster. 1995. Identification of the ligand-binding domain of the surface-located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol. Microbiol. 16:895-907.
19. McDevitt, D., P. Francois, P. Vaudaux, and T. J. Foster. 1994. Molecular characterization of the clumping factor (fibrinogen receptor) of Staphylococcus aureus. Mol. Microbiol. 11:237-248.
20. Ohlsson, A., and J. B. Lacy. 2004. Intravenous immunoglobulin for preventing infection in preterm and/or low-birth-weight infants. Cochrane Database Syst. Rev. [Online.] doi:10.1002/14651858.CD000361.pub2.
21. Patti, J. M., B. L. Allen, M. J. Mcgavin, and M. Hook. 1994. MSCRAMM-mediated adherence of microorganisms to host tissues. Ann. Rev. Microbiol. 48:585-617.
22. Patti, J. M., and M. Hook. 1994. Microbial adhesins recognizing extracellular matrix macromolecules. Curr. Opin. Cell Biol. 6:752-758.
23. Pei, L., and J. I. Flock. 2001. Lack of fbe, the gene for a fibrinogen-binding protein from Staphylococcus epidermidis, reduces its adherence to fibrinogen coated surfaces. Microb. Pathog. 31:185-193.
24. Rennermalm, A., M. Nilsson, and J. I. Flock. 2004. The fibrinogen binding protein of Staphylococcus epidermidis is a target for opsonic antibodies. Infect. Immun. 72:3081-3083.
25. Schiff, R. 1994. Intravenous gammaglobulin, 2: pharmacology, clinical uses and mechanisms of action. Pediatr. Allerg. Immunol. 5:127-156.
26. Siboo, I. R., A. L. Cheung, A. S. Bayer, and P. M. Sullam. 2001. Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect. Immun. 69:3120-3127.
27. Stoll, B. J., and N. Hansen. 2003. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin. Perinatol. 27:293-301.
28. Stoll, B. J., N. Hansen, A. A. Fanaroff, L. L. Wright, W. A. Carlo, R. A. Ehrenkranz, J. A. Lemons, E. F. Donovan, A. R. Stark, J. E. Tyson, W. Oh, C. R. Bauer, S. B. Korones, S. Shankaran, A. R. Laptook, D. K. Stevenson, L. A. Papile, and W. K. Poole. 2002. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110:285-291.
29. Vernachio, J., A. S. Bayer, T. Le, Y. L. Chai, B. Prater, A. Schneider, B. Ames, P. Syribeys, J. Robbins, and J. M. Patti. 2003. Anti-clumping factor A immunoglobulin reduces the duration of methicillin-resistant Staphylococcus aureus bacteremia in an experimental model of infective endocarditis. Antimicrob. Agents Chemother. 47:3400-3406.
30. Wisplinghoff, H., T. Bischoff, S. M. Tallent, H. Seifert, R. P. Wenzel, and M. Edmond. 2004. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39:309-317.
31. Yeaman, M. R., J. Lee, and A. S. Bayer. 1999. Experimental candida endocarditis, p. 1709-1720. In O. Zak and M. A. Sande (ed.), Handbook of animal model infections. Academic Press, New York, N. Y.